ArticleSoft computing2021
The prediction of the lifetime of the new coronavirus in the USA using mathematical models.
Article in Soft computing, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
- Evolving deep convolutional neutral network by hybrid sine-cosine and extreme learning machine for real-time COVID19 diagnosis from X-ray images.Soft computing · 2023Article
- Management of and Revitalization Strategy for Megacities Under Major Public Health Emergencies: A Case Study of Wuhan.Frontiers in public health · 2021Article
Corrections and comments
- Retraction · 2022-11-30Concerns/Issues about Referencing/Attributions · Compromised Peer Review · Rogue Editor · Unreliable Results and/or Conclusions ·
- Retracted
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The World Health Organization (WHO) on December 31, 2019, was informed of several cases of respiratory diseases of unknown origin in the city of Wuhan in the Chinese Province of Hubei, the clinical manifestations of which were similar to those of viral pneumonia and manifested as fever, cough, and shortness of breath. And, the disease caused by the virus is named the new coronavirus disease 2019 and it will be abbreviated as 2019-nCoV and COVID-19. As of January 30, 2020, the WHO classified this epidemic as a global health emergency (Chung et al. in Radiology 295(1):202-207, 2020). It is an international real-life problem. Due to deaths, globally everyone is under fear. Now, it is the responsibility of researchers to give hope to the people. In this article, we aim to better protect people and general pandemic preparedness by predicting the lifetime of the disease-causing virus using three mathematical models. This article deals with a complex real-life problem people face all over the world, an international real-life problem. The main focus is on the USA due to large infection and death due to coronavirus and thereby the life of every individual is uncertain. The death counts of the USA from February 29 to April 22, 2020, are used in this article as a data set. The death counts of the USA are fitted by the solutions of three mathematical models and a solution to an international problem is achieved. Based on the death rate, the lifetime of the coronavirus COVID-19 is predicted as 1464.76 days from February 29, 2020. That is, after March 2024 there will be no death in the USA due to COVID-19 if everyone follows the guidelines of WHO and the advice of healthcare workers. People and government can get prepared for this situation and many lives can be saved. It is the contribution of soft computing. Finally, this article suggests several steps to control the spread and severity of the disease. The research work, the lifetime prediction presented in this article is entirely new and differs from all other articles in the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.